Home › Companies › VOYAGER THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VOYAGER THERAPEUTICS INC.’s Form 8-K, filed June 6, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 5, 2024: 5 items on VOYAGER THERAPEUTICS INC.’s Form 8-K, filed June 6, 2024: 3 elected · 2 approved.
Notable dissent: 2 directors (18.3%, 17.3% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore VOYAGER THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VOYAGER THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael Higgins | 30,865,370 | -- | -- | 6,932,691 | 8,600,728 | 82% | Elected | — |
| Elect Director: Jude Onyia, Ph.D. | 34,864,862 | -- | -- | 2,933,199 | 8,600,728 | 92% | Elected | — |
| Elect Director: Nancy Vitale | 31,262,994 | -- | -- | 6,535,067 | 8,600,728 | 83% | Elected | — |
| Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers. | 35,949,375 | 1,711,367 | 137,319 | -- | 8,600,728 | 95% | Approved | — |
| Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 46,278,029 | 72,375 | 48,385 | -- | -- | 99.8% | Approved | — |
Source: VOYAGER THERAPEUTICS INC., Form 8-K, filed with the SEC on June 6, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
172 asset managers disclosed a vote on at least one VOYAGER THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Jude Onyia
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jude Onyia, Ph.D.”): 34,864,862 for, 2,933,199 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(a) Voyager's stockholders elected Michael Higgins, Jude Onyia, Ph.D., and Nancy Vitale, each to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, subject to his or her earlier death, resignation, or remov…”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,153,151 | 0 | 0 | 0 | For |
| BlackRock | 2,169,021 | 0 | 0 | 0 | For |
| State Street | 23,970 | 0 | 0 | 976,508 | Withhold |
| Dimensional | 0 | 0 | 0 | 870,340 | Withhold |
| T. Rowe Price | 792,317 | 0 | 0 | 0 | For |
| American Century | 786,861 | 0 | 0 | 0 | For |
| Federated Hermes | 534,308 | 0 | 0 | 0 | For |
| Fidelity | 433,441 | 0 | 0 | 0 | For |
| First Trust | 138,916 | 0 | 0 | 0 | For |
| MFS | 138,590 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 138,000 | 0 | 0 | 0 | For |
| Charles Schwab | 114,452 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 100,966 | 0 | 0 | 0 | For |
| Equitable | 96,012 | 0 | 0 | 0 | For |
| TIAA | 88,425 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 73,364 | 0 | 0 | 0 | For |
| SEI | 72,883 | 0 | 0 | 0 | For |
| AQR | 70,179 | 0 | 0 | 0 | For |
| WisdomTree | 60,766 | 0 | 0 | 0 | For |
| John Hancock | 50,549 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,122 | 0 | 0 | 31,537 | Mixed |
| EA Series Trust | 39,658 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 38,353 | 0 | 0 | 0 | For |
| Pacific Life | 35,131 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 32,025 | Withhold |
Fund voting reports, all 61 managers: 9,522,540 for, 1,913,126 withheld, 15,077 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 1,058,378 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,058,378 for.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Michael Higgins
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Higgins”): 30,865,370 for, 6,932,691 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(a) Voyager's stockholders elected Michael Higgins, Jude Onyia, Ph.D., and Nancy Vitale, each to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, subject to his or her earlier death, resignation, or remov…”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,153,151 | 0 | 0 | 0 | For |
| BlackRock | 2,169,021 | 0 | 0 | 0 | For |
| State Street | 986,092 | 0 | 0 | 14,386 | For |
| Dimensional | 0 | 0 | 0 | 870,340 | Withhold |
| T. Rowe Price | 792,317 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 786,861 | Withhold |
| Federated Hermes | 534,308 | 0 | 0 | 0 | For |
| Fidelity | 433,441 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 138,916 | Withhold |
| MFS | 0 | 0 | 0 | 138,590 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 138,000 | Withhold |
| Charles Schwab | 114,452 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 100,966 | Withhold |
| Equitable | 71,282 | 0 | 0 | 24,730 | Mixed |
| TIAA | 88,425 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 73,364 | 0 | 0 | 0 | For |
| SEI | 72,883 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 0 | 70,179 | Withhold |
| WisdomTree | 0 | 0 | 0 | 60,766 | Withhold |
| John Hancock | 37,492 | 0 | 13,057 | 0 | Mixed |
| Lincoln Financial | 26,300 | 0 | 0 | 17,359 | Mixed |
| EA Series Trust | 0 | 0 | 39,658 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 0 | 38,353 | Withhold |
| Pacific Life | 35,131 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 32,025 | Withhold |
Fund voting reports, all 61 managers: 8,707,034 for, 2,642,986 withheld, 100,723 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 0 | 0 | 1,058,378 | Withhold |
Institutional-manager reports, all 1 managers: 1,058,378 withheld.
Combines 3 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Nancy Vitale
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Nancy Vitale”): 31,262,994 for, 6,535,067 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(a) Voyager's stockholders elected Michael Higgins, Jude Onyia, Ph.D., and Nancy Vitale, each to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, subject to his or her earlier death, resignation, or remov…”
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,153,151 | 0 | 0 | 0 | For |
| BlackRock | 2,169,021 | 0 | 0 | 0 | For |
| State Street | 986,092 | 0 | 0 | 14,386 | For |
| Dimensional | 0 | 0 | 0 | 870,340 | Withhold |
| T. Rowe Price | 792,317 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 786,861 | Withhold |
| Federated Hermes | 534,308 | 0 | 0 | 0 | For |
| Fidelity | 433,441 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 138,916 | Withhold |
| MFS | 0 | 0 | 0 | 138,590 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 138,000 | Withhold |
| Charles Schwab | 114,452 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 100,966 | Withhold |
| Equitable | 96,012 | 0 | 0 | 0 | For |
| TIAA | 88,425 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 73,364 | 0 | 0 | 0 | For |
| SEI | 72,883 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 0 | 70,179 | Withhold |
| WisdomTree | 0 | 0 | 0 | 60,766 | Withhold |
| John Hancock | 37,492 | 0 | 13,057 | 0 | Mixed |
| Lincoln Financial | 26,300 | 0 | 0 | 17,359 | Mixed |
| EA Series Trust | 0 | 0 | 39,658 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 0 | 38,353 | Withhold |
| Pacific Life | 35,131 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 32,025 | Withhold |
Fund voting reports, all 61 managers: 8,749,042 for, 2,600,978 withheld, 100,723 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 0 | 0 | 1,058,378 | Withhold |
Institutional-manager reports, all 1 managers: 1,058,378 withheld.
Combines 11 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 97.5% for (June 6, 2023 meeting) ▼ 2.0 pts
Description as filed by funds: TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers.”): 35,949,375 for, 1,711,367 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(b) Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,153,151 | 0 | 0 | 0 | For |
| BlackRock | 2,169,021 | 0 | 0 | 0 | For |
| State Street | 998,111 | 2,367 | 0 | 0 | For |
| Dimensional | 870,340 | 0 | 0 | 0 | For |
| T. Rowe Price | 792,317 | 0 | 0 | 0 | For |
| American Century | 0 | 786,861 | 0 | 0 | Against |
| Federated Hermes | 534,308 | 0 | 0 | 0 | For |
| Fidelity | 433,441 | 0 | 0 | 0 | For |
| First Trust | 138,916 | 0 | 0 | 0 | For |
| MFS | 138,590 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 138,000 | 0 | 0 | Against |
| Charles Schwab | 114,452 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 100,966 | 0 | 0 | 0 | For |
| Equitable | 96,012 | 0 | 0 | 0 | For |
| TIAA | 88,425 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 73,364 | 0 | 0 | 0 | For |
| SEI | 72,883 | 0 | 0 | 0 | For |
| AQR | 70,179 | 0 | 0 | 0 | For |
| WisdomTree | 60,766 | 0 | 0 | 0 | For |
| John Hancock | 50,549 | 0 | 0 | 0 | For |
| Lincoln Financial | 43,659 | 0 | 0 | 0 | For |
| EA Series Trust | 39,658 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 38,353 | 0 | 0 | 0 | For |
| Pacific Life | 35,131 | 0 | 0 | 0 | For |
| Putnam | 32,025 | 0 | 0 | 0 | For |
Fund voting reports, all 61 managers: 10,504,981 for, 945,762 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 3,917,546 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 3,340,670 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 2,292,000 | 0 | 0 | 0 | For |
| State Street | 1,697,535 | 2,585 | 0 | 0 | For |
| BlackRock | 1,315,584 | 6,296 | 0 | 0 | For |
| T. Rowe Price | 1,061,671 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 1,058,378 | 0 | 0 | 0 | For |
| American Century | 0 | 794,057 | 0 | 0 | Against |
| Federated Hermes | 535,209 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 440,517 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 429,759 | 0 | 0 | 0 | For |
| JPMorgan | 304,375 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 284,908 | 0 | 0 | 0 | For |
| FIDUCIARY TRUST CO | 259,397 | 0 | 0 | 0 | For |
| Northern Trust | 216,345 | 0 | 0 | 0 | For |
| AQR | 204,614 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 197,458 | 0 | 0 | 0 | For |
| Wellington | 184,612 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 140,300 | 0 | 0 | Against |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 138,590 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 137,714 | 0 | 0 | 0 | For |
| Dimensional | 129,438 | 0 | 0 | 0 | For |
| CAPTRUST FINANCIAL ADVISORS | 121,471 | 0 | 0 | 0 | For |
| Charles Schwab | 114,452 | 0 | 0 | 0 | For |
| DE Shaw | 112,693 | 0 | 0 | 0 | For |
Institutional-manager reports, all 129 managers: 19,852,781 for, 1,280,206 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Prior year: 99.9% for (June 6, 2023 meeting) unchanged
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 46,278,029 for, 72,375 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(c) Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,153,151 | 0 | 0 | 0 | For |
| BlackRock | 2,169,021 | 0 | 0 | 0 | For |
| State Street | 998,779 | 1,699 | 0 | 0 | For |
| Dimensional | 870,340 | 0 | 0 | 0 | For |
| T. Rowe Price | 792,317 | 0 | 0 | 0 | For |
| American Century | 786,861 | 0 | 0 | 0 | For |
| Federated Hermes | 534,308 | 0 | 0 | 0 | For |
| Fidelity | 433,441 | 0 | 0 | 0 | For |
| First Trust | 138,916 | 0 | 0 | 0 | For |
| MFS | 138,590 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 138,000 | 0 | 0 | 0 | For |
| Charles Schwab | 114,452 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 100,966 | 0 | 0 | 0 | For |
| Equitable | 96,012 | 0 | 0 | 0 | For |
| TIAA | 88,425 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 73,364 | 0 | 0 | 0 | For |
| SEI | 72,883 | 0 | 0 | 0 | For |
| AQR | 70,179 | 0 | 0 | 0 | For |
| WisdomTree | 60,766 | 0 | 0 | 0 | For |
| John Hancock | 50,549 | 0 | 0 | 0 | For |
| Lincoln Financial | 43,659 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 39,658 | 0 | 0 | Against |
| ALPS ETF Trust | 38,353 | 0 | 0 | 0 | For |
| Pacific Life | 35,131 | 0 | 0 | 0 | For |
| Putnam | 32,025 | 0 | 0 | 0 | For |
Fund voting reports, all 61 managers: 11,409,386 for, 41,357 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 1,058,378 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,058,378 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 54,393,628 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.80% |
| 2 | BlackRock | 3.99% |
| 3 | State Street | 1.84% |
| 4 | Dimensional | 1.60% |
| 5 | T. Rowe Price | 1.46% |
| 6 | American Century | 1.45% |
| 7 | Federated Hermes | 0.98% |
| 8 | Fidelity | 0.80% |
| 9 | First Trust | 0.26% |
| 10 | MFS | 0.25% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | EcoR1 Capital, LLC | 7.20% |
| 2 | ARMISTICE CAPITAL, LLC | 6.14% |
| 3 | FARALLON CAPITAL MANAGEMENT LLC | 4.21% |
| 4 | State Street | 3.13% |
| 5 | BlackRock | 2.43% |
| 6 | T. Rowe Price | 1.95% |
| 7 | Erste Asset Management GmbH | 1.95% |
| 8 | American Century | 1.46% |
| 9 | Federated Hermes | 0.98% |
| 10 | Vestal Point Capital, LP | 0.81% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 5,607,271 | 10.31% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 3,250,066 | 5.98% | Form 13F, quarter ended March 31, 2024 |
| State Street | 1,749,168 | 3.22% | Form 13F, quarter ended March 31, 2024 |
| Dimensional Fund Advisors | 1,105,555 | 2.03% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 1,041,930 | 1.92% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 972,364 | 1.79% | Form 13F, quarter ended March 31, 2024 |
| AQR Capital | 793,634 | 1.46% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 599,688 | 1.10% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 389,816 | 0.72% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 297,573 | 0.55% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 54,393,628 shares outstanding, as reported by VOYAGER THERAPEUTICS INC. on its Form 10-Q dated May 8, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At VOYAGER THERAPEUTICS INC.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 172 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,092 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — VOYAGER THERAPEUTICS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VOYAGER THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VOYAGER THERAPEUTICS INC.’s 10-Q dated May 8, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
VOYAGER THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “VOYAGER THERAPEUTICS (VYGR) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/voyager-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.